ÖZDOĞAN, Ö. Et Al. 2021. Applying postoperative radioiodine therapy before 3 months seems to decrease ablation success in patients with differentiated thyroid carcinoma. ANNALS OF NUCLEAR MEDICINE , vol.35, no.2 , 223-231.

ÖZDOĞAN, Ö., Aksu, A., DOĞAN, E., BÜLBÜL, O., GÜRAY DURAK, M., SEVİNÇ, A. İ., ... Bayraktar, F.(2021). Applying postoperative radioiodine therapy before 3 months seems to decrease ablation success in patients with differentiated thyroid carcinoma. ANNALS OF NUCLEAR MEDICINE , vol.35, no.2, 223-231.

ÖZDOĞAN, ÖZHAN Et Al. "Applying postoperative radioiodine therapy before 3 months seems to decrease ablation success in patients with differentiated thyroid carcinoma," ANNALS OF NUCLEAR MEDICINE , vol.35, no.2, 223-231, 2021

ÖZDOĞAN, ÖZHAN Et Al. "Applying postoperative radioiodine therapy before 3 months seems to decrease ablation success in patients with differentiated thyroid carcinoma." ANNALS OF NUCLEAR MEDICINE , vol.35, no.2, pp.223-231, 2021

ÖZDOĞAN, Ö. Et Al. (2021) . "Applying postoperative radioiodine therapy before 3 months seems to decrease ablation success in patients with differentiated thyroid carcinoma." ANNALS OF NUCLEAR MEDICINE , vol.35, no.2, pp.223-231.

@article{article, author={ÖZHAN ÖZDOĞAN Et Al. }, title={Applying postoperative radioiodine therapy before 3 months seems to decrease ablation success in patients with differentiated thyroid carcinoma}, journal={ANNALS OF NUCLEAR MEDICINE}, year=2021, pages={223-231} }